Dana-Farber Cancer Institute

308 articles about Dana-Farber Cancer Institute

• Stop, Rewind: the Scientists Slowing the Ageing Process, Dana-Farber Cancer Institute Study

  1/26/2011

• Congestive Heart Failure Risk in Breast Cancer Higher With Bevacizumab, Dana-Farber Cancer Institute Study

  1/6/2011

• More Signs Lung Cancer Screening Could Save Lives, Dana-Farber Cancer Institute Study

  12/29/2010

• MannKind Corporation and Dana-Farber Cancer Institute Release: Presentation at American Society of Hematology Annual Meeting Confirms Inhibiting Unfolded Protein Response is Promising Treatment for Multiple Myeloma

  12/7/2010

• Dana-Farber Cancer Institute and Bay-Area Startup File Responses in Lawsuit Over Rights to Cancer Molecule

  11/10/2010

• Bay Area Biotech Startup, Gatekeeper Pharmaceuticals at Odds with Dana-Farber Cancer Institute and Novartis Corporation Over Cancer Drug Rights

  10/29/2010

• 'Smart Drug' Shrinks Aggressive Sarcoma and Lung Cancer, Dana-Farber Cancer Institute Study

  10/28/2010

• ESMO: New Agent Active in Advanced Ovarian Cancer, Dana-Farber Cancer Institute Study

  10/15/2010

• Dana-Farber Cancer Institute Completes Historic $1 Billion Capital Campaign

  10/1/2010

• Dana-Farber Cancer Institute Gets $33 Million in Sanofi-Aventis (France) Deal

  9/24/2010

• Vitamins' Impact on Colon Cancer Minimal: Dana-Farber Cancer Institute Study

  9/8/2010

• Immunotherapy Shows Benefit in Prostate Cancer, Dana-Farber Cancer Institute Study

  7/29/2010

• Dana-Farber Cancer Institute Study on GlaxoSmithKline's Avandia Raises Hope For Safer Diabetes Drugs

  7/22/2010

• Creation Of Self-Assembling Nanodevices That Move And Change Shape On Demand, Harvard University And Dana-Farber Cancer Institute Study

  6/23/2010

• Taking Aim at Metastatic Lung Tumors, Dana-Farber Cancer Institute Study

  6/15/2010

• Antibody Therapy Lengthens Survival of Metastatic Melanoma Patients in Large Clinical Trial, Dana-Farber Cancer Institute Study

  6/9/2010

• Red Sox and Dana-Farber Cancer Institute name Wakefield and Buchholz Jimmy Fund Co-Captains

  4/26/2010

• Immunovaccine Inc. Signs Research Agreement with Dana-Farber Cancer Institute

  4/22/2010

• Acetylon Pharmaceuticals Licenses Powerful Discovery Methodology and Platform from Harvard University and the Dana-Farber Cancer Institute for Development of Further Next-Generation Class II-Selective HDAC Inhibitor Compounds

  3/8/2010

• Vaccine Approach Extends Life of Metastatic Prostate Cancer Patients, Dana-Farber Cancer Institute Study

  1/26/2010